JP7523129B2 - ヘリコバクター・ピロリ菌株の同定方法、および同定用キット - Google Patents

ヘリコバクター・ピロリ菌株の同定方法、および同定用キット Download PDF

Info

Publication number
JP7523129B2
JP7523129B2 JP2020569692A JP2020569692A JP7523129B2 JP 7523129 B2 JP7523129 B2 JP 7523129B2 JP 2020569692 A JP2020569692 A JP 2020569692A JP 2020569692 A JP2020569692 A JP 2020569692A JP 7523129 B2 JP7523129 B2 JP 7523129B2
Authority
JP
Japan
Prior art keywords
type
helicobacter pylori
peptide
european
east asian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020569692A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020158811A1 (https=
JPWO2020158811A5 (https=
Inventor
義信 江石
佳介 内田
智也 掛川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Medical and Dental University NUC
Original Assignee
Tokyo Medical and Dental University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Medical and Dental University NUC filed Critical Tokyo Medical and Dental University NUC
Publication of JPWO2020158811A1 publication Critical patent/JPWO2020158811A1/ja
Publication of JPWO2020158811A5 publication Critical patent/JPWO2020158811A5/ja
Application granted granted Critical
Publication of JP7523129B2 publication Critical patent/JP7523129B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2020569692A 2019-01-31 2020-01-29 ヘリコバクター・ピロリ菌株の同定方法、および同定用キット Active JP7523129B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019015399 2019-01-31
JP2019015399 2019-01-31
PCT/JP2020/003201 WO2020158811A1 (ja) 2019-01-31 2020-01-29 ヘリコバクター・ピロリ菌株の同定方法、および同定用キット

Publications (3)

Publication Number Publication Date
JPWO2020158811A1 JPWO2020158811A1 (https=) 2020-08-06
JPWO2020158811A5 JPWO2020158811A5 (https=) 2022-01-26
JP7523129B2 true JP7523129B2 (ja) 2024-07-26

Family

ID=71841376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020569692A Active JP7523129B2 (ja) 2019-01-31 2020-01-29 ヘリコバクター・ピロリ菌株の同定方法、および同定用キット

Country Status (4)

Country Link
EP (1) EP3919503A4 (https=)
JP (1) JP7523129B2 (https=)
CN (1) CN113366012A (https=)
WO (1) WO2020158811A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119716051B (zh) * 2024-12-19 2025-08-12 无锡壹闪生物科技有限公司 抗幽门螺旋杆菌CagA亚型抗体检测试剂盒及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018153991A1 (en) 2017-02-24 2018-08-30 Biotome Pty Ltd Novel peptides and their use in diagnosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT946874E (pt) * 1996-12-19 2002-10-31 Chiron Corp Diagnostico de helicobacter pylori
JP2006284567A (ja) * 2005-03-08 2006-10-19 Pharma Foods International Co Ltd ヘリコバクター・ピロリ感染の診断方法及び診断キット
JP2008161113A (ja) * 2006-12-28 2008-07-17 Toyobo Co Ltd ヘリコバクター・ピロリ菌の識別方法
JP5376354B2 (ja) * 2008-03-27 2013-12-25 国立大学法人福井大学 胃癌発症危険群の選別方法
JP2009261318A (ja) * 2008-04-25 2009-11-12 Kansai Bunri Sogo Gakuen 分子多型の検出
JP5904481B2 (ja) * 2011-05-20 2016-04-13 学校法人関西文理総合学園 ピロリ菌の分泌毒素に結合するペプチドおよびその用途
JP2019015399A (ja) 2017-07-03 2019-01-31 小松マテーレ株式会社 ネジ状成形体
JP7222511B2 (ja) * 2018-06-28 2023-02-15 国立大学法人 大分大学 ペプチド及びその利用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018153991A1 (en) 2017-02-24 2018-08-30 Biotome Pty Ltd Novel peptides and their use in diagnosis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HATAKEYAMA M.，ONCOGENIC MECHANISMS OF THE HELICOBACTER PYLORI CagA PROTEIN，Nature Reviews. Cancer，2004年，Vol.4 No.9，Page.688-694
Yuichi Matsuo，Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody，World J Gastroenterol，2017年01月07日，Vol.23 No.1，Page.48-59
畠山昌則，ピロリ菌がん蛋白質CagA－その構造多型と胃発がんリスク，医学のあゆみ，2018年09月01日，Vol.266 No.9，Page.643-648
高田俊介等，Helicobactre pylori CagA hot spotに対するヒト血清抗体価測定系の確立，日本消化器病学会雑誌，2006年，Vol.103 臨時増刊号（総会），Page.A178

Also Published As

Publication number Publication date
EP3919503A4 (en) 2023-01-18
EP3919503A1 (en) 2021-12-08
JPWO2020158811A1 (https=) 2020-08-06
WO2020158811A1 (ja) 2020-08-06
CN113366012A (zh) 2021-09-07

Similar Documents

Publication Publication Date Title
WO2024001044A1 (zh) 一种与肺癌相关的生物标志物组合、含其的试剂盒及其用途
CN110178031A (zh) 寨卡病毒感染的血清学测定
CN110716050A (zh) 抗原组合在制备用于肺癌相关自身抗体检测的试剂盒中的用途以及相应的试剂盒和检测方法
CN113563479B (zh) 包虫病诊断试剂盒
EP4298113A1 (en) Peptides and their use in diagnosis of sars-cov-2 infection
JP5033127B2 (ja) 単純ヘルペスウイルス２型を検出するための方法および組成物
US20230221320A1 (en) Serological assays for sars-cov-2
KR101775851B1 (ko) 결핵 특이적 항원에 대한 항체반응검사를 이용한 결핵 진단 방법
JP5924502B2 (ja) リンパ球性漏斗下垂体後葉炎のバイオマーカー及びその用途
CN110662757A (zh) 新型肽及其在诊断中的应用
CN120334544B (zh) 鼻咽癌抗体标志物及其应用
JP7523129B2 (ja) ヘリコバクター・ピロリ菌株の同定方法、および同定用キット
WO2016072464A1 (ja) デオキシハイプシン・シンターゼ遺伝子を指標として用いる動脈硬化及びがんの検出方法
JP6357425B2 (ja) 干渉ペプチド及び微生物の検出方法
US20100047830A1 (en) Compositions and methods for detecting cancers in a subject
WO2018166079A1 (zh) 嗜吞噬细胞无形体蛋白aph1384的应用
JP6618107B2 (ja) リンパ球性漏斗下垂体後葉炎検査試薬及びその用途
CN111308090B (zh) 一种食管癌多联快速检测elisa试剂盒
WO2012100599A1 (zh) 过氧化物还原酶iv在制备类风湿关节炎体外诊断试剂中的应用
JP2020518575A (ja) 組成物並びに分析及び治療方法、及びその使用
KR102089268B1 (ko) 한탄바이러스 절단형 뉴클레오캡시드 단백질을 이용한 한탄바이러스 검출 방법
KR20200015276A (ko) 쯔쯔가무시균 유래 엑소좀을 이용한 쯔쯔가무시병의 진단방법
WO2026079284A1 (ja) 生体試料中のｄｏｐａデカルボキシラーゼを定量するための方法
KR20160139888A (ko) 결핵 특이적 항원에 대한 항체반응검사를 이용한 결핵 진단 방법
CN117203526A (zh) 用于检测血吸虫感染的蛋白质

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20210729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230116

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230414

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240403

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240620

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240708

R150 Certificate of patent or registration of utility model

Ref document number: 7523129

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350